Free tool
FAERS Monitor: Mucinex Dm
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 021620 or its brand name (Mucinex Dm, Dextromethorphan Hydrobromide, Guaifenesin). Reports on generic versions are filed under their own applications.
Reports
7,254
Serious
1,813
25% of reports
Hospitalization
571
Death reported
92
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective988
- dizziness861
- diarrhoea636
- accidental overdose542
- nausea509
- overdose389
- product use in unapproved indication355
- somnolence299
- feeling abnormal288
- headache287
- vomiting286
- dyspnoea278
- fatigue276
- insomnia268
- cough222
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 6 |
| 2007 | 21 |
| 2008 | 20 |
| 2009 | 77 |
| 2010 | 138 |
| 2011 | 126 |
| 2012 | 110 |
| 2013 | 140 |
| 2014 | 123 |
| 2015 | 202 |
| 2016 | 608 |
| 2017 | 774 |
| 2018 | 733 |
| 2019 | 658 |
| 2020 | 491 |
| 2021 | 239 |
| 2022 | 458 |
| 2023 | 650 |
| 2024 | 737 |
| 2025 | 591 |
| 2026 | 349 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,046,905 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| accidental overdoseSignal | 542 | 43.6 | 40.2 | 22,218 |
| overdoseSignal | 389 | 5.2 | 4.8 | 1,340 |
| dizzinessSignal | 861 | 5.0 | 4.7 | 2,823 |
| somnolenceSignal | 299 | 4.3 | 3.9 | 763 |
| product use in unapproved indicationSignal | 355 | 4.2 | 3.8 | 857 |
| feeling abnormalSignal | 288 | 3.5 | 3.1 | 514 |
| insomniaSignal | 268 | 2.9 | 2.6 | 340 |
| diarrhoeaSignal | 636 | 2.9 | 2.7 | 790 |
| coughSignal | 222 | 2.3 | 2.0 | 163 |
| drug ineffectiveSignal | 988 | 2.2 | 2.1 | 667 |
| nausea | 509 | 1.9 | 1.7 | 211 |
| vomiting | 286 | 1.8 | 1.6 | 96 |
| dyspnoea | 278 | 1.4 | 1.3 | 36 |
| headache | 287 | 1.3 | 1.2 | 24 |
| fatigue | 276 | 1.0 | 0.9 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.